PE20001061A1 - AEROSOLIZABLE PARTICLES RESISTANT TO HYGROSCOPIC GROWTH - Google Patents
AEROSOLIZABLE PARTICLES RESISTANT TO HYGROSCOPIC GROWTHInfo
- Publication number
- PE20001061A1 PE20001061A1 PE1999000925A PE00092599A PE20001061A1 PE 20001061 A1 PE20001061 A1 PE 20001061A1 PE 1999000925 A PE1999000925 A PE 1999000925A PE 00092599 A PE00092599 A PE 00092599A PE 20001061 A1 PE20001061 A1 PE 20001061A1
- Authority
- PE
- Peru
- Prior art keywords
- active agent
- hygroscopic
- particles
- hygroscopic growth
- refers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
SE REFIERE A PARTICULAS QUE CONTIENEN a)UN AGENTE ACTIVO; b)UN INHIBIDOR DE CRECIMIENTO HIGROSCOPICO TAL COMO FOSFOLIPIDOS DE CADENA DOBLE, CICLODEXTRINAS, HIDROETILALMIDON, DEXTRANO, DEXTRANOMERO, MALTODEXTRANO, HIDROXIPROPILCELULOSA, HIDROXIPROPILMETILCELULOSA, ETER HIDROXIETILICO DE ETILCELULOSA EN CANTIDAD SUFICIENTE PARA QUE LA PARTICULA EXHIBA UNA TASA DE ABSORCION DE HUMEDAD DE NO MAS DE 0,5% EN FUNCION DE LA HUMEDAD RELATIVA; O UN NIVEL DE ABSORCION DE AGUA DE NO MAS DE 30% EN PESO A UNA HUMEDAD RELATIVA DE 80%; LAS PARTICULAS SE CARACTERIZAN i)POR EXHIBIR UNA CAIDA DE LA DOSIS EMITIDA DE NO MAS DE 25% EN CONDICIONES SIMULADAS O EN CONDICIONES AMBIENTE DE POR LO MENOS 60%; ii)TIENEN UN INDICE DE SORCION INFERIOR A 6,5%; iii)TAMANO DE PARTICULAS ES INFERIOR A 3 MICRONES. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION QUE COMPRENDE PREPARAR UNA MEZCLA DE UN INHIBIDOR DEL CRECIMIENTO HIGROSCOPICO, UN AGENTE ACTIVO Y UN SOLVENTE (AGUA); SECAR POR ROCIO LA MEZCLA PARA OBTENER PARTICULAS HOMOGENEAS DEL AGENTE HIGROSCOPICO Y EL AGENTE ACTIVOREFERS TO PARTICLES CONTAINING a) AN ACTIVE AGENT; b) an inhibitor of hygroscopic GROWTH AS double-chain phospholipids, cyclodextrins, HIDROETILALMIDON, dextran, dextranomer, maltodextran, hydroxypropyl methyl cellulose ether hydroxyethyl ethylcellulose IN ENOUGH FOR PARTICLE exhibits absorption rate HUMIDITY NOT EXCEEDING 0.5% DEPENDING ON THE RELATIVE HUMIDITY; OR A WATER ABSORPTION LEVEL OF NO MORE THAN 30% BY WEIGHT AT A RELATIVE HUMIDITY OF 80%; THE PARTICLES ARE CHARACTERIZED i) BY EXHIBITING A DROP IN THE ISSUED DOSE OF NO MORE THAN 25% IN SIMULATED CONDITIONS OR IN AMBIENT CONDITIONS OF AT LEAST 60%; ii) THEY HAVE A SORPTION INDEX LESS THAN 6.5%; iii) PARTICLE SIZE IS LESS THAN 3 MICRONS. IT ALSO REFERS TO A PROCEDURE FOR THE PREPARATION THAT INCLUDES PREPARING A MIXTURE OF A HYGROSCOPIC GROWTH INHIBITOR, AN ACTIVE AGENT AND A SOLVENT (WATER); DRY THE MIXTURE BY SPRAY TO OBTAIN HOMOGENE PARTICLES OF THE HYGROSCOPIC AGENT AND THE ACTIVE AGENT
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10016398P | 1998-09-14 | 1998-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001061A1 true PE20001061A1 (en) | 2000-10-08 |
Family
ID=22278404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000925A PE20001061A1 (en) | 1998-09-14 | 1999-09-13 | AEROSOLIZABLE PARTICLES RESISTANT TO HYGROSCOPIC GROWTH |
Country Status (44)
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1198593C (en) | 1999-06-09 | 2005-04-27 | 罗伯特·E·希弗斯 | Supercritical fluid-assisted nebulization and bubble drying |
| US6475468B2 (en) * | 2001-02-15 | 2002-11-05 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
| CA2446904A1 (en) * | 2001-05-24 | 2003-04-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| EG24184A (en) * | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
| US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| BR0307935A (en) | 2002-02-25 | 2005-03-29 | Diffusion Pharmaceuticals Llc | Bipolar Trans Carotenoid Salts And Their Uses |
| JP2006513139A (en) * | 2002-07-03 | 2006-04-20 | ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド | Central airway administration for systemic delivery of therapeutic agents |
| ES2280835T3 (en) * | 2002-12-19 | 2007-09-16 | Pharmacia Corporation | NON-HYGROSCOPIC FORMULATION THAT INCLUDES A HYGROSCOPIC PHARMACO. |
| DE10338403A1 (en) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| CA2562585A1 (en) * | 2004-04-23 | 2005-11-10 | Cydex, Inc. | Dpi formulation containing sulfoalkyl ether cyclodextrin |
| CA2598882C (en) * | 2005-02-24 | 2020-02-25 | Diffusion Pharmaceuticals Llc | Trans carotenoids, their synthesis, formulation and uses |
| AU2006221364A1 (en) * | 2005-03-09 | 2006-09-14 | Ono Pharmaceutical Co., Ltd. | Particle and preparation containing the particle |
| SI2335707T1 (en) | 2005-10-26 | 2015-09-30 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| US20100269819A1 (en) * | 2006-08-14 | 2010-10-28 | Sievers Robert E | Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions |
| WO2008050847A1 (en) * | 2006-10-25 | 2008-05-02 | Dainippon Sumitomo Pharma Co., Ltd. | Granular preparation prevented from caking |
| EP1925295A1 (en) * | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stable powder formulation containing a new antichinolinergic agent |
| JP2010524855A (en) | 2007-04-13 | 2010-07-22 | ディフュージョン・ファーマシューティカルズ・エルエルシー | Use of bipolar trans carotenoids as and in the pretreatment of peripheral vascular disease |
| CN101878040A (en) | 2007-10-31 | 2010-11-03 | 扩散药品有限公司 | A new class of therapeutics that enhance small molecule diffusion |
| ES2661215T3 (en) | 2009-05-20 | 2018-03-28 | Aeras | Viral compositions; immunogens; spray dried; stable |
| AU2010263245A1 (en) | 2009-06-22 | 2012-01-19 | Diffusion Pharmaceuticals Llc | Diffusion enhancing compounds and their use alone or with thrombolytics |
| KR101891357B1 (en) | 2010-06-02 | 2018-08-24 | 디퓨젼 파마슈티컬즈 엘엘씨 | Oral formulations of bipolar trans carotenoids |
| SG10201607288VA (en) | 2012-05-03 | 2016-10-28 | Janssen Sciences Ireland Uc | Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections |
| BR112015010601B1 (en) * | 2012-11-09 | 2022-07-19 | Civitas Therapeutics, Inc. | PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION |
| WO2015042352A1 (en) * | 2013-09-20 | 2015-03-26 | Virginia Commonwealth University | Delivery of particles using hygroscopic excipients |
| DK3212212T3 (en) | 2014-10-31 | 2020-12-21 | Univ Monash | POWDER FORMULATION |
| KR20230014850A (en) | 2016-03-24 | 2023-01-30 | 디퓨젼 파마슈티컬즈 엘엘씨 | Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3155573A (en) * | 1958-05-06 | 1964-11-03 | Benger Lab Ltd | Inhalant composition and method of making same |
| ES2177544T3 (en) * | 1992-06-12 | 2002-12-16 | Teijin Ltd | ULTRAFININE POWDER TO INHALATE AND METHOD FOR PREPARATION. |
| US6524557B1 (en) * | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| DE69732306T2 (en) * | 1997-01-16 | 2006-01-12 | Massachusetts Institute Of Technology, Cambridge | PREPARATION OF PARTICLE MEDICINES FOR INHALATION |
| US6086376A (en) * | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
-
1999
- 1999-09-09 MA MA25762A patent/MA25590A1/en unknown
- 1999-09-13 MY MYPI99003947A patent/MY129282A/en unknown
- 1999-09-13 SK SK344-2001A patent/SK3442001A3/en unknown
- 1999-09-13 HU HU0103837A patent/HUP0103837A3/en unknown
- 1999-09-13 EE EEP200100151A patent/EE200100151A/en unknown
- 1999-09-13 IL IL14156299A patent/IL141562A0/en not_active IP Right Cessation
- 1999-09-13 EA EA200100300A patent/EA003476B1/en active IP Right Revival
- 1999-09-13 KR KR1020017003208A patent/KR20010075063A/en not_active Application Discontinuation
- 1999-09-13 CN CN99810871A patent/CN1317977A/en active Pending
- 1999-09-13 ID IDW20010582A patent/ID28845A/en unknown
- 1999-09-13 ZA ZA200101995A patent/ZA200101995B/en unknown
- 1999-09-13 PL PL99346768A patent/PL195574B1/en not_active IP Right Cessation
- 1999-09-13 UA UA2001031707A patent/UA76085C2/en unknown
- 1999-09-13 GE GEAP19995857A patent/GEP20043257B/en unknown
- 1999-09-13 PE PE1999000925A patent/PE20001061A1/en not_active Application Discontinuation
- 1999-09-13 CZ CZ2001829A patent/CZ2001829A3/en unknown
- 1999-09-13 EP EP99969035A patent/EP1117442A1/en not_active Withdrawn
- 1999-09-13 AU AU60397/99A patent/AU753014B2/en not_active Ceased
- 1999-09-13 AP APAP/P/2001/002093A patent/AP1374A/en active
- 1999-09-13 HN HN1999000159A patent/HN1999000159A/en unknown
- 1999-09-13 CA CA002343920A patent/CA2343920A1/en not_active Abandoned
- 1999-09-13 JP JP2000569846A patent/JP2002524535A/en not_active Withdrawn
- 1999-09-13 OA OA1200100063A patent/OA11781A/en unknown
- 1999-09-13 TR TR2001/01182T patent/TR200101182T2/en unknown
- 1999-09-13 TW TW088115876A patent/TWI226248B/en not_active IP Right Cessation
- 1999-09-13 WO PCT/US1999/021109 patent/WO2000015262A1/en not_active Application Discontinuation
- 1999-09-13 DZ DZ990192A patent/DZ2892A1/en active
- 1999-09-13 AR ARP990104587A patent/AR022090A1/en unknown
- 1999-09-13 BR BR9913722-4A patent/BR9913722A/en not_active IP Right Cessation
- 1999-09-13 NZ NZ510168A patent/NZ510168A/en unknown
- 1999-09-13 YU YU24201A patent/YU24201A/en unknown
- 1999-09-14 GT GT199900156A patent/GT199900156A/en unknown
- 1999-09-14 UY UY25711A patent/UY25711A1/en not_active Application Discontinuation
- 1999-09-14 CO CO99058265A patent/CO5130023A1/en unknown
- 1999-09-14 TN TNTNSN99173A patent/TNSN99173A1/en unknown
- 1999-09-14 PA PA19998481901A patent/PA8481901A1/en unknown
- 1999-10-31 SA SA99200718A patent/SA99200718B1/en unknown
-
2001
- 2001-02-21 IL IL141562A patent/IL141562A/en unknown
- 2001-03-05 IS IS5878A patent/IS5878A/en unknown
- 2001-03-13 NO NO20011251A patent/NO20011251L/en not_active Application Discontinuation
- 2001-03-14 LT LT2001021A patent/LT4897B/en not_active IP Right Cessation
- 2001-03-14 HR HR20010189A patent/HRP20010189A2/en not_active Application Discontinuation
- 2001-03-14 LV LV010041A patent/LV12658B/en unknown
- 2001-04-10 BG BG105430A patent/BG105430A/en unknown
-
2002
- 2002-03-06 HK HK02101738.3A patent/HK1042231A1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20001061A1 (en) | AEROSOLIZABLE PARTICLES RESISTANT TO HYGROSCOPIC GROWTH | |
| AR018891A1 (en) | PRESSURIZED INHALERS OF DOSAGE MEASUREMENT AND PHARMACEUTICAL FORMULATIONS IN AEROSOL | |
| CY1116503T1 (en) | PHARMACEUTICAL COMPOSITIONS FOR INHIBITION IN THE FORM OF DRY POWDER, SOLUTIONS OR DOLLARS | |
| AR048711A1 (en) | FUNGICIDE WATER COMPOSITION AND ITS USE TO COMBAT HARMFUL MICROORGANISMS | |
| AR068612A1 (en) | Aqueous MICROEMULSIONS CONTAINING ORGANIC INSECTICIDE COMPOUNDS | |
| RU2008127860A (en) | PHARMACEUTICAL COMPOSITION FOR SULFUR-CONTAINING MEDICINES IN LIQUID DOSED FORMS | |
| DE60116758D1 (en) | Encapsulation of a toxic to a non-toxic region in an oral formulation | |
| ES2226514B2 (en) | STABILIZED ORAL PHARMACEUTICAL COMPOSITION CONTAINING IODIDE AND IODATE TO TREAT IODINE DEFICIENCY DISEASES, AND METHOD TO PREPARE IT. | |
| ES2182351T3 (en) | PHARMACEUTICAL COMPOSITION IN AEROSOL. | |
| BR112015015136B1 (en) | DENTAL PASTE COMPOSITION, ORAL HYGIENE PROMOTION METHOD AND NON-THERAPEUTIC USE OF A DENTAL PASTE COMPOSITION | |
| BRPI0413957A (en) | process for preparing water soluble diterpenes, aqueous solution and their applications | |
| AR058323A1 (en) | FORMULATION OF SUSPENSION OF FEXOPHENADINE | |
| NO20063108L (en) | Stabilized liquid interferon formulations | |
| BR0110351A (en) | Storage stable biocidal aerated gel composition, rodent control method, insect control method, and preparation method of a storage stable aerated biocidal gel composition | |
| ES2301455T1 (en) | ANTIACID PHARMACEUTICAL COMPOSITION IN DUST FORM; PHARMACEUTICAL PREPARATION CONTAINING THE SAME AND PROCEDURE FOR PREPARATION. | |
| CN103392730B (en) | Methidathion Pickering emulsion in water and preparation method thereof | |
| US20030059446A1 (en) | Physically stable sprayable gel composition | |
| CN105288652A (en) | Superoxide dismutase microcapsule powder and preparation method thereof | |
| FI962056A (en) | New pharmaceutical composition for the manufacture of stable powder containing as active ingredient a combination of acetylsalicylic acid and methoclopramide | |
| WO2016017784A1 (en) | Water-containing fluid composition, method for producing same, processed lysozyme and/or salt thereof, and method for producing same | |
| CN105194686A (en) | Inclusion compound containing camphor oil and preparation method thereof | |
| CN114344200A (en) | DEET sustained-release gel and preparation method and application thereof | |
| AR001349A1 (en) | New pharmaceutical composition containing trimebutine and a process for its preparation. | |
| US2448180A (en) | Medicinal composition | |
| Nicole et al. | Persistent virucidal activity in an alcohol-based sanitizer formulation (ProtecTeaV) for potential use against norovirus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |